Annexon, Inc. (ANNX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

180 KIMBALL WAY SOUTH SAN FRANCISCO, CA 94080

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is deploying a rigorous, biomarker-driven development strategy designed to improve the probability of technical success over shorter development timelines.

Data as of 2021-10-09 10:49:08 -0400
Market Cap773.545 Million Shares Outstanding38.332 Million Avg 30-day Volume281.681 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-6.71 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.6263 52-week High/Low38.01 / 15.52 Next Earnings Date2021-11-15 Price to Cash FLow (P/CF) -26.9495
Data provided by IEX Cloud
View SEC Filings from ANNX instead.

View recent insider trading info

Funds Holding ANNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

27.2 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

27.2 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MATTHEAKIS LARRY CHIEF SCIENTIFIC OFFICER

  • Officer
220,000 2021-09-30 2

LOVE DOUGLAS PRESIDENT & CEO

  • Officer
  • Director
37,994 2021-09-16 5

LEW JENNIFER EVP & CHIEF FINANCIAL OFFICER

  • Officer
145,793 2021-09-13 4

YEDNOCK TED EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
78,554 2021-09-13 4

WADDILL WILLIAM D.

  • Director
20,000 2021-08-12 2

WIGGANS THOMAS G

  • Director
10,000 2021-06-02 1

SATTER MUNEER A

  • Director
10,000 2021-06-02 1

CHOI JUNG

  • Director
10,000 2021-06-02 1

SUN RICKY

  • Director
10,000 2021-06-02 1

CARSON WILLIAM H.

  • Director
10,000 2021-06-02 3

KESWANI SANJAY EVP & CHIEF MEDICAL OFFICER

  • Officer
182,956 2021-03-24 2

OVERDORF MICHAEL EVP & CHIEF BUSINESS OFFICER

  • Officer
115,000 2021-02-25 1

FLYNN JAMES E

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2020-07-28 0

CLARUS LIFESCIENCES III, L.P.

CLARUS VENTURES III GP, L.P.

BLACKSTONE CLARUS III L.L.C.

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE HOLDINGS I/II GP L.L.C.

BLACKSTONE GROUP INC

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
No longer subject to file 2020-07-28 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
No longer subject to file 2020-07-28 0

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

BAIN CAPITAL LIFE SCIENCES FUND, L.P.

BCIP LIFE SCIENCES ASSOCIATES, LP

KOPPEL ADAM

BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

SCHWARTZ JEFFREY LAWRENCE

  • 10% Owner
No longer subject to file 2020-07-28 0

MAKOWER JOSHUA

  • 10% Owner
0 2020-07-23 0

YOUNG WILLIAM

  • Director
0 2020-07-23 0

SANDELL SCOTT D

  • 10% Owner
0 2020-07-23 0

BASKETT FOREST

  • 10% Owner
0 2020-07-23 0

GALLAGHER CAROL GILTNER

  • Director
0 2020-07-23 0

SONSINI PETER W.

  • 10% Owner
0 2020-07-23 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
0 2020-07-23 0

NEW ENTERPRISE ASSOCIATES 15, L.P.

NEA PARTNERS 15, L.P.

NEA 15 GP, LLC

  • 10% Owner
0 2020-07-23 0

MAKHZOUMI MOHAMAD

  • 10% Owner
0 2020-07-23 0

CUNNINGHAM EMMETT

  • Director
0 2020-07-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MATTHEAKIS LARRY - Officer CHIEF SCIENTIFIC OFFICER

2021-10-04 18:31:37 -0400 2021-09-30 A 220,000 a 220,000 direct

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-09-20 17:46:03 -0400 2021-09-16 M 7,500 $1.41 a 7,500 direct 0.7153 -1.2399 6.5331 5 -1.2399 6

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-09-20 17:46:03 -0400 2021-09-16 M 7,500 d 37,994 direct

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-09-20 17:46:03 -0400 2021-09-16 S 7,500 $22.05 d 0 direct yes 0.7153 -1.2399 6.5331 5 -1.2399 6

LEW JENNIFER - Officer EVP & CHIEF FINANCIAL OFFICER

2021-09-15 18:35:08 -0400 2021-09-13 M 3,500 $7.49 a 5,500 direct 0.5898 -0.9528 0.5898 2 -4.8548 4

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-09-15 18:35:58 -0400 2021-09-13 S 16,190 $20.00 d 0 direct yes 0.5898 -0.9528 0.5898 2 -4.8548 4

LEW JENNIFER - Officer EVP & CHIEF FINANCIAL OFFICER

2021-09-15 18:35:08 -0400 2021-09-13 M 3,500 d 143,793 direct

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-09-15 18:35:58 -0400 2021-09-13 M 1,190 d 67,939 direct

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-09-15 18:35:58 -0400 2021-09-13 M 1,190 $5.11 a 16,190 direct 0.5898 -0.9528 0.5898 2 -4.8548 4

LEW JENNIFER - Officer EVP & CHIEF FINANCIAL OFFICER

2021-09-15 18:35:08 -0400 2021-09-13 S 3,500 $20.01 d 2,000 direct yes 0.5898 -0.9528 0.5898 2 -4.8548 4

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-09-15 18:35:58 -0400 2021-09-13 M 15,000 d 10,615 direct

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-09-15 18:35:58 -0400 2021-09-13 M 15,000 $1.41 a 15,000 direct 0.5898 -0.9528 0.5898 2 -4.8548 4

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ANNEXON INC ANNX 2021-10-15 22:15:04 UTC -0.2708 0.3408 85000
ANNEXON INC ANNX 2021-10-15 21:45:03 UTC -0.2708 0.3408 85000
ANNEXON INC ANNX 2021-10-15 21:15:03 UTC -0.2708 0.3408 85000
ANNEXON INC ANNX 2021-10-15 20:45:03 UTC -0.1887 0.2587 85000
ANNEXON INC ANNX 2021-10-15 20:15:03 UTC -0.1887 0.2587 85000
ANNEXON INC ANNX 2021-10-15 19:45:03 UTC -0.1887 0.2587 85000
ANNEXON INC ANNX 2021-10-15 19:15:04 UTC -0.1887 0.2587 85000
ANNEXON INC ANNX 2021-10-15 18:45:03 UTC -0.18 0.25 85000
ANNEXON INC ANNX 2021-10-15 18:15:03 UTC -0.18 0.25 85000
ANNEXON INC ANNX 2021-10-15 17:45:03 UTC -0.18 0.25 85000
ANNEXON INC ANNX 2021-10-15 17:15:03 UTC -0.18 0.25 85000
ANNEXON INC ANNX 2021-10-15 16:45:03 UTC -0.18 0.25 85000
ANNEXON INC ANNX 2021-10-15 16:15:03 UTC -0.18 0.25 85000
ANNEXON INC ANNX 2021-10-15 15:45:03 UTC -0.18 0.25 85000
ANNEXON INC ANNX 2021-10-15 15:15:03 UTC -0.18 0.25 85000
ANNEXON INC ANNX 2021-10-15 14:45:02 UTC -0.2378 0.3078 85000
ANNEXON INC ANNX 2021-10-15 14:15:03 UTC -0.2378 0.3078 85000
ANNEXON INC ANNX 2021-10-15 13:45:03 UTC -0.2378 0.3078 85000
ANNEXON INC ANNX 2021-10-15 13:15:03 UTC -0.2378 0.3078 85000
ANNEXON INC ANNX 2021-10-15 12:45:03 UTC -0.2378 0.3078 85000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments